美国肯堡(Kimble)    
    肯堡玻璃有限公司（英文名称：Kimble Glass Inc.）成立于1901年，是一家注册于美国商业登记处的有限责任公司。自1994起为格雷斯海姆集团有限责任公司（英文名称：Gerresheimer Group GmbH）全资子公司。全球知名的肯堡玻璃有限公司为一家专门从事制药、生物工艺和科研市场特种玻璃业务的倍受青睐的国际领先公司，是全球知名的高质量实验室玻璃器皿产品的制造及分销商。
    肯堡玻璃有限公司在全球范围内制造和分销耐用性与一次性耗材类玻璃器皿，包括医药类、科研类、教育类专业玻璃器皿。
其业务范围包括：医药用玻璃器皿；模压玻璃；实验室玻璃仪器；玻璃管棒材。制造和供应链管理技术的发展，以及市场上生物制药和生物工艺技术的突飞猛进，令肯堡实验器皿有限公司须不断重组其业务经营。肯堡实验器皿有限公司将一如既往地继续进行其工艺再设计、更新其产能，以便为其客户提供更优质的服务。
    肯堡玻璃有限公司已拓展了其全球业务经营范围，并携手格雷斯海姆集团有限责任公司位于欧洲和拉丁美洲的其它19家制造厂提供全面的产品和服务系列。肯堡有能力完成其因大范围合并而服务的以未来为导向的市场上常见的国际竞标和承包工作。
    北京博美华龙玻璃仪器有限公司2003年8月正式成立。是北京玻璃仪器厂和北京朝龙玻璃仪器有限公司合资的企业。 它是北京玻璃仪器厂灯工、磨口、刻度部份及该厂技术交流站与民营企业朝龙玻璃仪器有限公司合资组建。北京博美华龙玻璃仪器有限公司的成立,集中了国企设备优势和人才优势以及五十年的生产经验,传承了玻璃仪器生产的精髓，同时也保留了民营企业吃苦耐劳，对用户全心全意的工作作风。生产产品为博美”牌硼硅玻璃制品、实验玻璃器皿及生物和医药用玻璃产品等。合资组建以来，管理水平不继提高，生产规模日益扩大，产品远销国内外市场。两强携手共建的肯堡博美（北京）实验器皿有限公司是一家有限责任公司，各方以各自认缴的出资额对合资公司的债务承担责任，各方按其出资额在注册资本中的比例分享利润，承担风险和亏损。合资公司利用北京博美华龙玻璃仪器有限公司现有条件和构筑的发展平台，和从格雷斯海姆集团有限公司引入技术、管理及国际销售网络，取得优良的经济效益，最终使合资公司成为全球领先的硼硅玻璃实验室仪器供应商，通过我们长期的努力，用我们世界级的产品品质与服务来赢得优厚的回报。
Specialists in Producing Glass

Kimble Glass Inc. is a respected global leader in specialized glass for the pharmaceutical,
biotechnology and scientific research markets. We are a customer-driven company, dedicated
to the continuous improvement in manufacturing and the highest quality of products and
services.

Strong Market Position

Our strategic thrust has been to back our innovation and service positions with strong account
management and service integrity. As a result, we have maintained strong loyal customer
relationships, which are key to our businesses.

International Presence

Kimble has expanded its worldwide scope of activities. Combined with 16 other Gerresheimer
Group manufacturing plants in Europe and Latin America, Kimble provides comprehensive
product and service options. We are able to fulfill competitive global bids and contracts that
are now commonplace in the future-oriented markets we serve due to extensive consolidation.

Strategic Focus

The company was founded in 1901 and has belonged to Gerresheimer Glass AG since 1994.
Today, as we commemorate our centennial year, we are at yet another milestone. Technological
advances in manufacturing and supply chain management along with significant leaps in
biopharmaceutical and biotechnological breakthroughs in the markets we serve require constant
restructuring of our businesses. As in the past, we will continue to re-engineer our processes
and update our capabilities and capacity to better serve our customers. The new owners have
considerable financial strength and long term interest in continuing the successful strategy of
the Gerrresheimer Group.